Skip to main content

Qiagen, GeneArt Add Insect, Mammalian Synthetic Genes to Marketing Collaboration

NEW YORK (GenomeWeb News) – GeneArt said today it has extended its strategic collaboration with Qiagen to include the sale of synthetic genes optimized for mammalian and insect cells online through Qiagen’s GeneGlobe web portal.
 
GeneArt said it will optimize and synthesize the QIAgenes, which will be aimed at customers in the pharmaceutical and biotechnology industries and academia.
 
The companies agreed in May of this year to collaborate on marketing a set of plasmids containing synthetic genes that represent the entire human genome.
 
“Since the launch of our expression kits for use in E. coli cells in May, we have received a high number of requests for these two additional options,” Qiagen Global Product Manager Ute Boronowsky said in a statement.
 
GeneArt also said that marketing the QIAgenes products as a standardized catalog product complements the company’s existing business to tailor gene sequences for individual customer requests.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.